Negative symptoms and psychosocial functioning in schizophrenia: Neglected but important targets for treatment

European Psychiatry

Volumn 27, Issue 6, 2012, Pages 432-436

  Hunter, R ^a,b   Barry, S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GARTNAVEL ROYAL HOSPITAL   (United Kingdom)

Author keywords

Drug target; Negative symptoms; Psychosocial function; Schizophrenia

Indexed keywords

ARTICLE; CORRELATION ANALYSIS; DISEASE DURATION; EDUCATIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; WELLBEING;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 84863866584     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2011.02.015     Document Type: Article

References (19)

1. Bates D., Maechler M. Linear mixed effects models using S4 classes 2010.
2. Buchanan R.W. Persistent negative symptoms in schizophrenia: an overview. Schizophr Bull 2007, 33(4):1013-1022.
3. de Haan L., Weisfelt M., Dingemans P.M.A.J., Linszen D.H., Wouters L. Psychometric properties of the subjective well-being under neuroleptics scale and the subjective deficit syndrome scale. Psychopharmacology 2002, 162(1):24-28.
4. Diggle P.J., Heagerty P., Liang K.-Y., Zeger S.L. Analysis of longitudinal data. 2002, Vol. 2. Oxford University Press Inc, Clarendon.
5. Peuskens J., Gorwood P. On behalf of the EGOFORS initiative. How are we assessing functioning in schizophrenia? A need for a consensus approach. Eur Psychiatry 2011, (this issue).
6. Helldin L., Cavallaro R., Galderisi S. On behalf of the EGOFORS initiative. To measure functional outcome - what does a proper finding need to be based on?. Eur Psychiatry 2011, (this issue).
7. Hunter R., Cameron R., Norrie J. Using Patient-Reported Outcomes in Schizophrenia: The Scottish Schizophrenia Outcomes Study. Psychiatr Serv 2009, 60(2):240-245.
8. Hunter R., McLean J., Peck D., Pullen I., Greenfield A., Macri T., et al. The Scottish 700 Outcomes Study: a Comparative Evaluation of the Health of the Nation Outcome Scale (HoNOS), the Avon Mental Health Measure (AVON), and an Idiographic Scale. J Ment Health 2004, 13(1):93-105.
9. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 2006, 32(2):214-219.
10. Kraepelin E. Dementia praecox and paraphrenia translated by Barclay RM. 1919 1971, RE Krieger, New York.
11. Krzanowski W.J. Principles of multivariate analysis 1988, Oxford University Press, New York.
12. Leucht S., Corves C., Arbter D., Engel R.R., Li C.B., Davis J.M. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009, 373(9657):31-41.
13. NICE. Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care (update). National Clinical Practice Guideline Number 82, National Collaborating Centre for Mental Health. 2009, National Institute for Health and Clinical Excellence: London, UK.
14. Peyser H. What is recovery? A commentary. Psychiatr Serv 2001, 52(4):486-487.
15. R Foundation for Statistical Computing 2010, Development Core Team R: a language and environment for statistical computing, version 2.11.1 (2010-05-31), Vienna, Austria.
16. What's it worth? The social and economic costs of mental health problems in Scotland 2007, SAMH, Scottish Association for Mental Health, Sainsbury Centre for Mental Health, UK.
17. Thornicroft G., Tansella M., Becker T., Knapp M., Leese M., Schene A., et al. The personal impact of schizophrenia in Europe. Schizophr Res 2004, 69(2-3):125-132.
18. Venables W.N., Ripley B.D. Modern Applied Statistics with S 2002, Springer-Verlag, New York. 4th ed.
19. Wiersma D., Wanderling J., Dragomirecka E., Ganev K., Harrison G., an der Heiden W., et al. Social disability in schizophrenia: its development and prediction over 15years in incidence cohorts in six European centres. Psychol Med 2000, 30(5):1155-1167.